| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3904654 | Urology | 2008 | 5 Pages |
Abstract
The time to PSA nadir, combined with the PSA nadir level, can be used to identify men who are at high risk of PCSM after a short course of AST for entry onto clinical trials using novel systemic agents with AST.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Christine S. Chung, Ming-Hui Chen, Jennifer Cullen, David McLeod, Peter Carroll, Anthony V. D'Amico,